Inhibition of motility in isolated horse small intestine is mediated by κ but not µ opioid receptors.

The research article investigates how certain drugs, targeting specific opioid receptors, impact the movement of the small intestine in horses. The outcomes show that the κ (kappa) opioid receptors seem to affect this movement, but the µ (mu) receptors demand more studying.

Study Design

• The research involves exploration of various drugs that preferentially target specific types of opioid receptors like µ (mu) and κ (kappa). These drugs include morphine, fentanyl, the compound U69593, naloxone, and naloxonazine.
• The drugs were tested on muscle tissue samples taken from the jejunum (a part of the horse’s small intestine). These tissues were observed under isolated conditions in organ baths. This allowed for controlled analysis of drug-induced modifications of both spontaneous and electrically evoked contractile activity.

Results

• The findings showed that none of the opioid-targeted drugs caused a significant shift in spontaneous contractions of the small intestine muscles.
• Both fentanyl and U69593, however, did decrease the contractions induced electrically, while morphine had only a very slight impact.
• The antagonistic drug naloxone could counteract the effects of U69593, but both naloxone and another antagonist, naloxonazine, were ineffective at reversing contraction inhibition caused by fentanyl. This suggests that the contraction inhibition by fentanyl likely isn’t mediated by opioid receptors, but could be a result of the drug’s anticholinergic activity.

Conclusions

• The study concludes that κ (kappa) opioid receptors have a significant impact on the motility of the horse’s small intestine. More precisely, they seem to inhibit this movement.
• On the other hand, the µ (mu) opioid receptors appear to have a less significant role and hence, require further research for a more comprehensive understanding.